Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol

Research output: Contribution to journal › Research article › Contributed › peer-review

Contributors

  • Anette-Gabriele Ziegler - (Author)
  • Peter Achenbach - (Author)
  • Reinhard Berner - , Department of Paediatrics (Author)
  • Kristina Casteels - (Author)
  • Thomas Danne - (Author)
  • Melanie Guendert - (Author)
  • Joerg Hasford - (Author)
  • Verena Sophia Hoffmann - (Author)
  • Olga Kordonouri - (Author)
  • Karin Lange - (Author)
  • Helena Elding Larsson - (Author)
  • Markus Lundgren - (Author)
  • Matthew D. Snape - (Author)
  • Agnieszka Szypowska - (Author)
  • John A. Todd - (Author)
  • Ezio Bonifacio - , Center for Regenerative Therapies Dresden (Author)

Details

Original languageEnglish
Article numbere028578
JournalBMJ open
Volume9
Issue number6
Publication statusPublished - Jun 2019
Peer-reviewedYes

External IDs

Scopus 85068461302
ORCID /0000-0002-8704-4713/work/141544339

Keywords

Research priority areas of TU Dresden

DFG Classification of Subject Areas according to Review Boards

Sustainable Development Goals

Library keywords